Key Findings
The North American anti-aging market generated a revenue of $XX billion in 2018 and is projected to reach $XX billion by 2027, at a CAGR of 7.64%. The base year considered for the market study is 2018 and the forecasted period is between 2019 and 2027. Canada and the United States are considered for the market study.

Market Insights
The United States anti-aging market is significantly driven by rise in the aging population, a growing number of aesthetic plastic surgeries procedures along with the emergence of numerous anti-aging product startups.

The rise in the aging population would increase the demand for anti-aging products and devices owing to growing awareness about aging issues and rising standard of living. As a result, the adoption of anti-aging devices and products would increase, thereby contributing to the growth of the anti-aging market across the United States over the forecast period.

Competitive Insights
Revlon, Lumenis Ltd. (acquired by Xio), L’or?al S.A., Allergan Australia PTY Ltd., Solta Medical (Valeant Pharmaceuticals), Beiersdorf (acquired by Tchibo Holding AG), Avon Products, Inc., Alma Laser Inc. (acquired by Fosun Pharma), Cynosure (acquired by Hologic), Lutronic Corporation, Olay (acquired by Procter & Gamble), Personal Microderm, Syneron Candela, Coty Inc., and Photomedex, Inc. (acquired by Radiancy, Inc.) are the major companies which have been exhaustively profiled in the report.